These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11755940

  • 1. Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1.
    Böhm F, Johansson BL, Hedin U, Alving K, Pernow J.
    Atherosclerosis; 2002 Jan; 160(1):215-22. PubMed ID: 11755940
    [Abstract] [Full Text] [Related]

  • 2. Big endothelin-3 constricts forearm resistance vessels but not hand veins in humans.
    Ferro CJ, Strachan FE, Shepherd E, Haynes WG, Webb DJ.
    Clin Pharmacol Ther; 2000 Jul; 68(1):67-74. PubMed ID: 10945317
    [Abstract] [Full Text] [Related]

  • 3. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
    Zimmermann M, Jung CS, Vatter H, Raabe A, Seifert V.
    Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endothelin-converting enzyme activity in human cerebral circulation.
    Vatter H, Mursch K, Zimmermann M, Zilliken P, Kolenda H, Seifert V, Schilling L.
    Neurosurgery; 2002 Aug; 51(2):445-51; discussion 451-2. PubMed ID: 12182783
    [Abstract] [Full Text] [Related]

  • 6. Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells.
    Davenport AP, Kuc RE, Mockridge JW.
    J Cardiovasc Pharmacol; 1998 Aug; 31 Suppl 1():S1-3. PubMed ID: 9595383
    [Abstract] [Full Text] [Related]

  • 7. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage.
    Juvela S.
    J Neurosurg; 2002 Dec; 97(6):1287-93. PubMed ID: 12507125
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vasoconstrictor activity of novel endothelin peptide, ET-1(1 - 31), in human mammary and coronary arteries in vitro.
    Maguire JJ, Kuc RE, Davenport AP.
    Br J Pharmacol; 2001 Nov; 134(6):1360-6. PubMed ID: 11704658
    [Abstract] [Full Text] [Related]

  • 10. Measurement of C-terminal fragment of big endothelin-1: a novel method for assessing the generation of endothelin-1 in humans.
    Plumpton C, Haynes WG, Webb DJ, Davenport AP.
    J Cardiovasc Pharmacol; 1995 Nov; 26 Suppl 3():S34-6. PubMed ID: 8587408
    [Abstract] [Full Text] [Related]

  • 11. An investigation into the direct and indirect venoconstrictor effects of endothelin-1 and big endothelin-1 in man.
    Haynes WG, Moffat S, Webb DJ.
    Br J Clin Pharmacol; 1995 Oct; 40(4):307-11. PubMed ID: 8554931
    [Abstract] [Full Text] [Related]

  • 12. Coexpression of endothelin-converting enzyme-1 and endothelin-1 in different stages of human atherosclerosis.
    Ihling C, Szombathy T, Bohrmann B, Brockhaus M, Schaefer HE, Loeffler BM.
    Circulation; 2001 Aug 21; 104(8):864-9. PubMed ID: 11514370
    [Abstract] [Full Text] [Related]

  • 13. Effect of chronic ethanol consumption on endothelin-1 generation and conversion of exogenous big-endothelin-1 by the rat carotid artery.
    Tirapelli CR, Casolari DA, Yogi A, Tostes RC, Legros E, Lanchote VL, Uyemura SA, de Oliveira AM.
    Alcohol; 2007 Mar 21; 41(2):77-85. PubMed ID: 17466482
    [Abstract] [Full Text] [Related]

  • 14. Modulation of functionally active endothelin-converting enzyme by chronic neutral endopeptidase inhibition in experimental atherosclerosis.
    Grantham JA, Schirger JA, Wennberg PW, Sandberg S, Heublein DM, Subkowski T, Burnett JC.
    Circulation; 2000 Apr 25; 101(16):1976-81. PubMed ID: 10779465
    [Abstract] [Full Text] [Related]

  • 15. Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities.
    Rizzi A, Calo G, Battistini B, Regoli D.
    J Cardiovasc Pharmacol; 1998 Apr 25; 31 Suppl 1():S58-61. PubMed ID: 9595400
    [Abstract] [Full Text] [Related]

  • 16. Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease.
    Maguire JJ, Davenport AP.
    Br J Pharmacol; 1998 Sep 25; 125(2):238-40. PubMed ID: 9786493
    [Abstract] [Full Text] [Related]

  • 17. [Phe22]-big endothelin-1[19-37]: a new and potent inhibitor of the endothelin-converting enzyme.
    Claing A, Neugebauer W, Yano M, Rae GA, D'Orléans-Juste P.
    J Cardiovasc Pharmacol; 1995 Sep 25; 26 Suppl 3():S72-4. PubMed ID: 8587472
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory activities of metal chelators on endothelin-converting enzyme. II. In vivo studies.
    Ashizawa N, Okumura H, Kobayashi F, Aotsuka T, Asakura R, Arai K, Ashikawa N, Matsuura A.
    Biol Pharm Bull; 1994 Feb 25; 17(2):212-6. PubMed ID: 8205118
    [Abstract] [Full Text] [Related]

  • 19. Diabetes-associated changes and role of N epsilon-(carboxymethyl)lysine in big ET-1-induced coronary vasoconstriction.
    Matsumoto T, Ozawa Y, Taguchi K, Kobayashi T, Kamata K.
    Peptides; 2010 Feb 25; 31(2):346-53. PubMed ID: 19962413
    [Abstract] [Full Text] [Related]

  • 20. Endothelin converting enzyme (ECE) activity in human vascular smooth muscle.
    Maguire JJ, Johnson CM, Mockridge JW, Davenport AP.
    Br J Pharmacol; 1997 Dec 25; 122(8):1647-54. PubMed ID: 9422810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.